Patents by Inventor Colum Dunne
Colum Dunne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11951253Abstract: A positive exhalation pressure device (1) is described. The device (1) comprises a housing (2) having an annular chamber (5), a chamber inlet (6) configured to permit air into the chamber, a chamber outlet (7) configured to permit air out of the chamber, and a mouthpiece (8) in fluid communication with the chamber inlet. A movable body such as a ball (3) is disposed in the housing within the annular chamber and configured to revolve around the annular chamber in response to flow of air through the chamber from the chamber inlet to the chamber outlet. The movable body is configured to at least partially block the chamber outlet as it revolves around the annular chamber causing cyclical fluctuations in airflow resistance.Type: GrantFiled: September 15, 2020Date of Patent: April 9, 2024Assignee: Solopep LimitedInventors: Kevin J. O'Sullivan, Leonard W. O'Sullivan, Colum Dunne, Barry Linnane, Deirdre McGrath
-
Publication number: 20230210502Abstract: An air sampling device (1) for collecting airborne microorganisms comprising an air inlet piece (2), an air outlet piece (3) and a filter chamber (4) for receiving a filter (5) between the air inlet piece (2) and the air outlet piece (3) wherein the sampling device (1) comprises an openable fastener (6) to provide ease of access to the filter chamber (4).Type: ApplicationFiled: April 28, 2021Publication date: July 6, 2023Inventors: Frank Keane, Colum Dunne
-
Publication number: 20220214357Abstract: The Applicant has discovered a cytokine profile that can accurately distinguish between ulcerative colitis (UC) and Crohn's disease (CD) in a subject having, or having symptoms of, inflammatory bowel disease (IBD). The profile of ulcerative colitis is increased IL-10 levels (compared with a reference IL-10 level, and decreased IL-23 levels (compared with a reference IL-23 level). The cytokine profile can be detected at a protein or genomic level, and is generally determined from a peripheral blood sample (i.e. a blood fraction such as serum, plasma, or blood cells such as peripheral blood mononuclear cells). Distinguishing between UC and CD in a subject with IBD allows a clinician prescribe a suitable therapeutic regime for the subject using a non-invasive blood test, and avoiding the need for scoping or tissue biopsy, which are undesirable for the subject. The cytokine profile can also be used to monitor a therapeutic regime for effectiveness.Type: ApplicationFiled: May 4, 2020Publication date: July 7, 2022Applicant: University of LimerickInventors: Colum DUNNE, J. Calvin COFFEY, Miranda KIERNAN
-
Publication number: 20210001067Abstract: A positive exhalation pressure device (1) is described. The device (1) comprises a housing (2) having an annular chamber (5), a chamber inlet (6) configured to permit air into the chamber, a chamber outlet (7) configured to permit air out of the chamber, and a mouthpiece (8) in fluid communication with the chamber inlet. A movable body such as a ball (3) is disposed in the housing within the annular chamber and configured to revolve around the annular chamber in response to flow of air through the chamber from the chamber inlet to the chamber outlet. The movable body is configured to at least partially block the chamber outlet as it revolves around the annular chamber causing cyclical fluctuations in airflow resistance.Type: ApplicationFiled: September 15, 2020Publication date: January 7, 2021Applicant: Solopep LimitedInventors: Kevin J. O'SULLIVAN, Leonard W. O'SULLIVAN, Colum DUNNE, Barry LINNANE, Deirdre McGRATH
-
Patent number: 10806876Abstract: A positive exhalation pressure device (1) is described. The device (1) comprises a housing (2) having an annular chamber (5), a chamber inlet (6) configured to permit air into the chamber, a chamber outlet (7) configured to permit air out of the chamber, and a mouthpiece (8) in fluid communication with the chamber inlet. A movable body such as a ball (3) is disposed in the housing within the annular chamber and configured to revolve around the annular chamber in response to flow of air through the chamber from the chamber inlet to the chamber outlet. The movable body is configured to at least partially block the chamber outlet as it revolves around the annular chamber causing cyclical fluctuations in airflow resistance.Type: GrantFiled: December 19, 2016Date of Patent: October 20, 2020Assignee: Solopep LimitedInventors: Kevin J. O'Sullivan, Leonard W. O'Sullivan, Colum Dunne, Barry Linnane, Deirdre McGrath
-
Publication number: 20170173282Abstract: A positive exhalation pressure device (1) is described. The device (1) comprises a housing (2) having an annular chamber (5), a chamber inlet (6) configured to permit air into the chamber, a chamber outlet (7) configured to permit air out of the chamber, and a mouthpiece (8) in fluid communication with the chamber inlet. A movable body such as a ball (3) is disposed in the housing within the annular chamber and configured to revolve around the annular chamber in response to flow of air through the chamber from the chamber inlet to the chamber outlet. The movable body is configured to at least partially block the chamber outlet as it revolves around the annular chamber causing cyclical fluctuations in airflow resistance.Type: ApplicationFiled: December 19, 2016Publication date: June 22, 2017Applicant: University of LimerickInventors: Kevin J. O'Sullivan, Leonard W. O'Sullivan, Colum Dunne, Barry Linnane, Deirdre McGrath
-
Patent number: 8545497Abstract: Apparatus (20) for carrying out a prophylactic or treatment procedure on tissue comprises a device (21) having a chamber (22) and at least one active element such as an electrode (23) within the chamber (22). The chamber (22) has an opening (26) through which tissue is drawn into the chamber (22). Means for drawing the tissue into the chamber may comprise a vacuum lumen with vacuum orifices (25) in the chamber (22). Treatment such as electroporation may be applied to tissue in the chamber (22).Type: GrantFiled: September 22, 2006Date of Patent: October 1, 2013Assignee: University College Cork—National University of Ireland, CorkInventors: Anthony Morrissey, Declan Soden, Gerald O'Sullivan, Christopher Collins, Colum Dunne, John Piggott, Denton A. M Prior, Andrew Watson, Peter McGeehin
-
Publication number: 20100317734Abstract: An antimicrobial composition comprising a blend of two or more natural free fatty acids derivable from milk serum lipid, the free fatty acids being selected from: butyric (C4); caproic (C6); caprylic (C8); capric (C10); lauric (C12); myristic (C14); palmitic (C 16): palmitoleic 5 (C16:1); stearic (C1 8); oleic (C18:1); linoleic (Cl 8:2); linolenic (C18:3); and esterified derivatives thereof, and a milk, protein as an emulsifying agent for the free fatty acids wherein at least 35% of the total lipid content comprises free fatty acids selected from one or more of: butyric, caproic, caprylic, capric and lauric.Type: ApplicationFiled: December 4, 2008Publication date: December 16, 2010Inventors: Michael Anthony Folan, Colm O'Brien, Colum Dunne
-
Publication number: 20100196352Abstract: Use of whey protein isolate in the preparation of a composition for increasing mean aerobic capacity, enhanced haemoglobin production, enhanced red blood cell production and increased mean corpuscular haemoglobin concentration in competitive species, such as equine species, involved in strenuous activity. The composition may further comprise a prebiotic such as a fructo-oligosaccharide for example inulin.Type: ApplicationFiled: May 2, 2008Publication date: August 5, 2010Inventors: Patrick O'Donovan, Colum Dunne, Joseph Murphy, Christopher Miller
-
Publication number: 20070179535Abstract: Apparatus (20) for carrying out a prophylactic or treatment procedure on tissue comprises a device (21) having a chamber (22) and at least one active element such as an electrode (23) within the chamber (22). The chamber (22) has an opening (26) through which tissue is drawn into the chamber (22). Means for drawing the tissue into the chamber may comprise a vacuum lumen with vacuum orifices (25) in the chamber (22). Treatment such as electroporation may be applied to tissue in the chamber (22).Type: ApplicationFiled: September 22, 2006Publication date: August 2, 2007Inventors: Anthony Morrissey, Declan Soden, Gerald O'Sullivan, Christopher Collins, Colum Dunne, John Piggott, Denton Prior, Andrew Watson, Peter McGeehin
-
Publication number: 20070128252Abstract: A nutritional supplement composition having a therapeutically effective amount of peptides is provided for the treatment of body weight conditions. The nutritional supplement may also comprise milk minerals, such as calcium and/or be combined with a protein source including ?-casein fragment 106-169. The nutritional supplement composition is administered in amounts effective for limiting weight gain and/or enhancing weight loss, as well as promoting overall good health, in the treatment of body weight conditions, including overweight and obesity. In one embodiment, the supplement is administered through a calorically restricted diet.Type: ApplicationFiled: October 27, 2006Publication date: June 7, 2007Applicant: Glanbia Nutritionals (Ireland) LimitedInventors: Loren Ward, Eric Bastian, Starla Paulsen, Colum Dunne
-
Publication number: 20020081311Abstract: An adherence factor comprises a cell wall associated adhesin derived from Lactobacillus or a derivative, fragment, precursor or mutant of the adhesin, the adherence factor mediating adherence to epithelial cells and modulating gene expression to improve gut barrier function and gastrointestinal tract homeostasis.Type: ApplicationFiled: May 14, 2001Publication date: June 27, 2002Inventors: Fergus Shanahan, John Kevin Collins, Barry Kialy, Colum Dunne, Gerald O'Sullivan, Liam O'Mahony